Fianlimab (LAG3/CD223) - Research Grade Biosimilar
Product Specifications
Background
The antibody drug against LAG-3 is indicated for malignant tumors.
Immunogen
Homo sapiens / LAG3/CD223 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer, Immunology
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
REGN3767
More Discoveries
Explore Other Products
Browse additional items from our catalog
MF-0135166-01 5 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details MF-0135166-02 10 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details MF-0135166-03 20 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details 
MF-0135166-04 50 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details 
MF-0135166-05 100 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details MF-0135166-06 200 µg
KRAS Protein, Human, Recombinant (G12C & Q61H, His)
Sign In for Pricing
View Details